Abstract: A soft magnetic alloy includes a main component of (Fe(1?(?+?))X1?X2?)(1?(a+b+c+d+e))MaBbPcSidCe. X1 is one or more of Co and Ni. X2 is one or more of Al, Mn, Ag, Zn, Sn, As, Sb, Cu, Cr, Bi, N, O, and rare earth elements. M is one or more of Nb, Hf, Zr, Ta, Mo, W, and V. 0.020?a?0.14 is satisfied. 0.020<b?0.20 is satisfied. 0?d?0.060 is satisfied. ??0 is satisfied. ??0 is satisfied. 0??+??0.50 is satisfied. c and e are within a predetermined range. The soft magnetic alloy has a nanohetero structure or a structure of Fe based nanocrystallines.

Abstract: [Problems] Thermoplastic resins have various problems such as enhancement in strength and improvement in toughness and heat resistance and copolymerization with monomers or oligomers and grafting have been carried out to solve the problems. Although graft polymerization with macromonomers has been carried out as a method for solving the problems, it is still expected to develop a modification technique for attaining better performance and resins produced by the technique. [Means for Solving Problems] A thermoplastic resin obtained by addition polymerization of an addition-polymerizable monomer, characterized by being modified by copolymerization with a vinyl polymer (I) which bears at least one group having a polymerizable carbon-carbon double bond at each of at least two molecular ends and which has a weight-average molecular weight (Mw)/number-average molecular weight (Mn) ratio of less than 1.8.

Abstract: Each of a pair of electrodes has a conductive face adapted to be brought into contact with a living body. A connector has a pair of terminals. Each of a pair of lead wires has a first end connected to one of the electrodes and a second end connected to one of the terminals. The electrodes, the connector and the lead wires constitute a biomedical electrode unit. A package body is adapted to hermetically packages the biomedical electrode unit in such a condition that the conductive faces of the electrodes are separatably adhered to each other, that the lead wires are coiled, and that the terminals are short-circuited by a conductive member.

Abstract: An object of the present invention is to provide a process for producing a vinyl polymer terminated with a group having a polymerizable carbon-carbon double bond with improved stability of quality. The present invention provides a process for producing a vinyl polymer terminated with a group having a polymerizable carbon-carbon double bond, the process being characterized by adding a stable free radical compound as a polymerization inhibitor. By adding the stable free radical compound during production, it is possible to prevent an increase in viscosity and gelation of the polymer which are due to polymerization reaction of the terminal group having the polymerizable carbon-carbon double bond.

Abstract: Each of a pair of electrodes has a conductive face adapted to be brought into contact with a living body. A connector has a pair of terminals. Each of a pair of lead wires has a first end connected to one of the electrodes and a second end connected to one of the terminals. The electrodes, the connector and the lead wires constitute a biomedical electrode unit. A package body is adapted to hermetically packages the biomedical electrode unit in such a condition that the conductive faces of the electrodes are separatably adhered to each other, that the lead wires are coiled, and that the terminals are short-circuited by a conductive member.

Abstract: A method of producing a polyoxyalkylene polymer having at least one crosslinkable silyl group and at least one hydroxyl group in each molecule which comprises treating a polyoxyalkylene polymer having at least one unsaturated group and at least one alcoholic hydroxyl group in each molecule and an impurity double metal cyanide complex as mixed therein with a metal-coordinating compound and adding a compound having a hydrogen-silicon bond and a crosslinkable silyl group in each molecule and a hydrosilylation catalyst to thereby carry out the hydrosilylation reaction.

Abstract: A method of producing a polyoxyalkylene polymer having at least one crosslinkable silyl group and at least one hydroxyl group in each molecule

Abstract: A method and apparatus is disclosed to reduce noise which overlaps detected signals in a common frequency band for detection of distributed signals from multiple measurement points. The method decomposes a input signal into a noise-free part called basic signal and a noise-overlapping part called residual signal. Noise contained in residual signal is recognized by comparing it with a comparison signal. The comparison signal corresponding to a measurement point is computed by a linear combination of all other points weighted with parameters which reflect amplitude relationship of distributed signals and are calculated during a learning phase at the beginning of measurement. With residual signal and corresponding comparison signal, a noise index is calculated and then used to extract signal components from the residual signal. The extracted signal components are added to basic signal as the output of the method. The method is effective in reducing signal-overlapping noise with little distortion of signal.

Abstract: A method and circuit for sampling input waveform signals at a predetermined periodic rate by detecting a peak and a bottom value during each period. The method further includes holding a peak value and a bottom value of an input waveform signal whenever they are generated as hold values and resetting the hold value to the current input waveform signal level so as to obtain a high-fidelity sampling output. The peak level or the bottom level is generated as a sampling value according to which is operating, the peak hold or bottom hold, at the sampling time. If both are currently not operating, then outputting the hold which was the last in operation.

Abstract: The purpose of the present invention is to provide a physiological signal amplifier circuitry exhibiting higher common mode rejection ratio with no necessity of adjustment. To realize this, outputs of the differential amplifiers are average to produce reference potential which is supplied, through a high gain amplifier, to invert terminals of the same differential amplifier as well as to invert terminals of other differential amplifiers connected to other electrodes. In the embodiment employed for the electrocardiograph, the reference potential is produced by the differential amplifier connected to extremity electrodes, and other differential amplifiers are connected to the chest electrodes.

Abstract: A pulse transformer for use in a switching power supply having primary and secondary windings wound concentrically around a common core and two electrostatic shield foils interposed between the primary and secondary windings with an insulator disposed between the electrostatic shield foils.